Also trades as: HLS.TO (TSX) · $vol 0M
HLTRF OTC
HLS Therapeutics Inc.
1W: -1.4%
1M: +4.2%
3M: -8.3%
YTD: -19.8%
1Y: -27.6%
3Y: -37.8%
5Y: -80.8%
$2.75
-0.04 (-1.43%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$56M
Revenue
-0.2% YoY
$-9M
Net Income
+43.1% YoY
$18M
Free Cash Flow
+51.1% YoY
80.6%
Gross Margin
-7.9%
Op. Margin
-7.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-14.1%
ROA-6.2%
ROIC-4.2%
Valuation
P/E-10.3
P/B1.7
EV/EBITDA7.1
Leverage
Debt/Equity0.76
Current Ratio1.05
Interest Cov.-0.8x
Quality Scores
Piotroski F5/9
Altman Z-1.07
Beneish M-3.56